ARTEMISMED347.00

Artemis Medicare Services Limited

· Pharma & Health
₹ CrorePeersINDRAMEDCOSHALBYGKSLGPTHEALTHLOTUSEYEDRAGARWQKMCSHILKOVAIMcap ₹5,493 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation40.345.248.1
+ Finance Costs27.828.527.7
+ Interest Income-4.3-26.6-24.3
+ Share-based Payments2.20.90.0
+ Unrealised FX (Gain) / Loss0.00.10.1
+ Other Non-cash Items2.13.02.4
+ Other Reconciling Items-8.0-2.6-4.1
Changes in Working Capital
+ Inventories3.90.1-3.4
+ Trade Receivables — Current-3.7-9.7-20.7
+ Other Financial Assets — Current0.5-3.50.4
+ Other Financial Assets — Non-current-0.1-1.00.0
+ Other Current Assets-0.4-4.3-9.3
+ Other Non-current Assets-11.10.30.0
+ Trade Payables — Current7.57.1-1.4
+ Other Financial Liabilities — Current-11.26.8-14.4
+ Other Current Liabilities-1.24.42.0
+ Provisions — Current1.31.56.4
+ Provisions — Non-current0.61.50.0
Cash from Operating Activities
Profit Before Tax (per I/S)68.5107.7139.2152.0
+ Total Adjustments (incl. Working Capital)46.251.89.3
Cash from Operations (pre-tax)114.7159.5148.5
+ Income Taxes Paid5.813.816.6
Cash from Operating Activities108.9145.6131.9
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)72.693.2104.9
+ Disp of Fixed Assets0.32.64.9
+ Loans & Advances Made0.00.03.6
+ Interest Received — Investing3.912.528.7
+ Other Inflows / (Outflows) — Investing-18.7-307.3-15.2
Cash from Investing Activities-87.0-385.4-90.0
Cash from Financing Activities
+ Proceeds from Issue of Shares2.00.20.2
+ Proceeds from Debentures / Notes / Bonds0.0330.00.0
+ Proceeds from Borrowings45.320.864.2
+ Repayment of Borrowings33.335.977.8
+ Payment of Lease Liabilities9.19.76.7
+ Interest Paid27.823.623.5
+ Dividends Paid6.16.06.1
+ Other Inflows / (Outflows) — Financing-1.1-9.1-0.3
Cash from Financing Activities-30.1266.7-50.1
Net Changes in Cash (pre-FX)-8.327.0-8.2
Net Changes in Cash-8.327.0-8.2
Closing Cash14.6
Reference Items
EBITDA132.7151.8188.2203.2
EBITDA Margin %15.1016.2017.4018.25
Free Cash Flow (CFO − Capex)36.352.527.027.0
Free Cash Flow to Equity21.1-15.5
Free Cash Flow per Basic Share2.293.311.711.71
Price to Free Cash Flow203.45
Cash Flow to Net Income2.211.771.27
Cash Paid for Taxes5.813.816.6
Cash Paid for Interest27.823.623.5
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.